Literature DB >> 26173962

A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease.

Daria Diodato1, Giorgio Tasca1, Daniela Verrigni1, Adele D'Amico1, Teresa Rizza1, Giulia Tozzi1, Diego Martinelli2, Margherita Verardo1, Federica Invernizzi3, Alessia Nasca3, Emanuele Bellacchio4, Daniele Ghezzi3, Fiorella Piemonte1, Carlo Dionisi-Vici2, Rosalba Carrozzo1, Enrico Bertini1.   

Abstract

AIFM1 is a gene located on the X chromosome, coding for AIF (Apoptosis-Inducing Factor), a mitochondrial flavoprotein involved in caspase-independent cell death. AIFM1 mutations have been associated with different clinical phenotypes: a severe infantile encephalopathy with combined oxidative phosphorylation deficiency and the Cowchock syndrome, an X-linked Charcot-Marie-Tooth disease (CMTX4) with axonal sensorimotor neuropathy, deafness and cognitive impairment. In two male cousins with early-onset mitochondrial encephalopathy and cytochrome c oxidase (COX) deficiency, we identified a novel AIFM1 mutation. Muscle biopsies and electromyography in both patients showed signs of severe denervation. Our patients manifested a phenotype that included signs of both cortical and motor neuron involvement. These observations emphasize the role of AIF in the development and function of neurons.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26173962      PMCID: PMC4755377          DOI: 10.1038/ejhg.2015.141

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death.

Authors:  N Joza; S A Susin; E Daugas; W L Stanford; S K Cho; C Y Li; T Sasaki; A J Elia; H Y Cheng; L Ravagnan; K F Ferri; N Zamzami; A Wakeham; R Hakem; H Yoshida; Y Y Kong; T W Mak; J C Zúñiga-Pflücker; G Kroemer; J M Penninger
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

2.  Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing.

Authors:  Itai Berger; Ziva Ben-Neriah; Talia Dor-Wolman; Avraham Shaag; Ann Saada; Shamir Zenvirt; Annick Raas-Rothschild; Michel Nadjari; Klaus H Kaestner; Orly Elpeleg
Journal:  Mol Genet Metab       Date:  2011-09-24       Impact factor: 4.797

Review 3.  From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1.

Authors:  Matthias Kettwig; Max Schubach; Franz A Zimmermann; Lars Klinge; Johannes A Mayr; Saskia Biskup; Wolfgang Sperl; Jutta Gärtner; Peter Huppke
Journal:  Mitochondrion       Date:  2015-01-10       Impact factor: 4.160

4.  Redox-linked conformational dynamics in apoptosis-inducing factor.

Authors:  Irina F Sevrioukova
Journal:  J Mol Biol       Date:  2009-05-15       Impact factor: 5.469

5.  Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology.

Authors:  Vincent El Ghouzzi; Zsolt Csaba; Paul Olivier; Benjamin Lelouvier; Leslie Schwendimann; Pascal Dournaud; Catherine Verney; Pierre Rustin; Pierre Gressens
Journal:  J Neuropathol Exp Neurol       Date:  2007-09       Impact factor: 3.685

6.  Cowchock syndrome is associated with a mutation in apoptosis-inducing factor.

Authors:  Carlo Rinaldi; Christopher Grunseich; Irina F Sevrioukova; Alice Schindler; Iren Horkayne-Szakaly; Costanza Lamperti; Guida Landouré; Marina L Kennerson; Barrington G Burnett; Carsten Bönnemann; Leslie G Biesecker; Daniele Ghezzi; Massimo Zeviani; Kenneth H Fischbeck
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

7.  X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder.

Authors:  F S Cowchock; S W Duckett; L J Streletz; L J Graziani; L G Jackson
Journal:  Am J Med Genet       Date:  1985-02

8.  The harlequin mouse mutation downregulates apoptosis-inducing factor.

Authors:  Jeffrey A Klein; Chantal M Longo-Guess; Marlies P Rossmann; Kevin L Seburn; Ronald E Hurd; Wayne N Frankel; Roderick T Bronson; Susan L Ackerman
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

9.  Clinical and molecular findings in children with complex I deficiency.

Authors:  M Bugiani; F Invernizzi; S Alberio; E Briem; E Lamantea; F Carrara; I Moroni; L Farina; M Spada; M A Donati; G Uziel; M Zeviani
Journal:  Biochim Biophys Acta       Date:  2004-12-06

10.  Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns.

Authors:  Alicia Lundby; Kasper Lage; Brian T Weinert; Dorte B Bekker-Jensen; Anna Secher; Tine Skovgaard; Christian D Kelstrup; Anatoliy Dmytriyev; Chunaram Choudhary; Carsten Lundby; Jesper V Olsen
Journal:  Cell Rep       Date:  2012-08-16       Impact factor: 9.423

View more
  27 in total

1.  Epigenome-wide DNA methylation in placentas from preterm infants: association with maternal socioeconomic status.

Authors:  Hudson P Santos; Arjun Bhattacharya; Elizabeth M Martin; Kezia Addo; Matt Psioda; Lisa Smeester; Robert M Joseph; Stephen R Hooper; Jean A Frazier; Karl C Kuban; T Michael O'Shea; Rebecca C Fry
Journal:  Epigenetics       Date:  2019-05-21       Impact factor: 4.528

2.  Defining NADH-Driven Allostery Regulating Apoptosis-Inducing Factor.

Authors:  Chris A Brosey; Chris Ho; Winnie Z Long; Sukrit Singh; Kathryn Burnett; Greg L Hura; Jay C Nix; Gregory R Bowman; Tom Ellenberger; John A Tainer
Journal:  Structure       Date:  2016-11-03       Impact factor: 5.006

3.  AIF loss deregulates hematopoiesis and reveals different adaptive metabolic responses in bone marrow cells and thymocytes.

Authors:  Lauriane Cabon; Audrey Bertaux; Marie-Noëlle Brunelle-Navas; Ivan Nemazanyy; Laurianne Scourzic; Laure Delavallée; Laura Vela; Mathieu Baritaud; Sandrine Bouchet; Cécile Lopez; Vu Quang Van; Kevin Garbin; Danielle Chateau; Françoise Gilard; Marika Sarfati; Thomas Mercher; Olivier A Bernard; Santos A Susin
Journal:  Cell Death Differ       Date:  2018-01-11       Impact factor: 15.828

Review 4.  Riboflavin in Neurological Diseases: A Narrative Review.

Authors:  Domenico Plantone; Matteo Pardini; Giuseppe Rinaldi
Journal:  Clin Drug Investig       Date:  2021-04-22       Impact factor: 2.859

5.  Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.

Authors:  Jiannan Chen; Zhe Zhao; Hongrui Shen; Qi Bing; Nan Li; Xuan Guo; Jing Hu
Journal:  BMC Neurol       Date:  2022-05-16       Impact factor: 2.903

6.  A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes.

Authors:  B Hu; M Wang; R Castoro; M Simmons; R Dortch; R Yawn; J Li
Journal:  Eur J Neurol       Date:  2017-10-07       Impact factor: 6.089

7.  A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation.

Authors:  Paula Sancho; Ana Sánchez-Monteagudo; Antonio Collado; Clara Marco-Marín; Cristina Domínguez-González; Ana Camacho; Erwin Knecht; Carmen Espinós; Vincenzo Lupo
Journal:  Neurogenetics       Date:  2017-10-03       Impact factor: 2.660

Review 8.  Mitochondrial cytochrome c oxidase deficiency.

Authors:  Malgorzata Rak; Paule Bénit; Dominique Chrétien; Juliette Bouchereau; Manuel Schiff; Riyad El-Khoury; Alexander Tzagoloff; Pierre Rustin
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

9.  Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked AIFM1 variant.

Authors:  Tonya Moss; Melanie May; Heather Flanagan-Steet; Raymond Caylor; Yong-Hui Jiang; Marie McDonald; Michael Friez; Allyn McConkie-Rosell; Richard Steet
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-06-11

Review 10.  Molecular Insights into Mitochondrial Protein Translocation and Human Disease.

Authors:  Eduardo Ruiz-Pesini; Julio Montoya; David Pacheu-Grau
Journal:  Genes (Basel)       Date:  2021-07-01       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.